These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1817 related items for PubMed ID: 11399510

  • 1. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 2. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P.
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [Abstract] [Full Text] [Related]

  • 3. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 4. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
    Hiddemann W, Wörmann B, Reuter C, Schleyer E, Zühlsdorf M, Böckmann A, Büchner T.
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449
    [Abstract] [Full Text] [Related]

  • 5. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
    Duru F, Ertem U, Taçyildiz N, Kirazli S.
    J Med; 1995 Dec; 26(5-6):241-52. PubMed ID: 8721901
    [Abstract] [Full Text] [Related]

  • 6. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis.
    Peters BG, Adkins DR, Harrison BR, Velasquez WS, Dunphy FR, Petruska PJ, Bowers CE, Niemeyer R, McIntyre W, Vrahnos D, Auberry SE, Spitzer G.
    Bone Marrow Transplant; 1996 Jul; 18(1):93-102. PubMed ID: 8832001
    [Abstract] [Full Text] [Related]

  • 7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B, Olofsson T, Lenhoff S.
    Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 9. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z, Talpaz M, Zipf TF, Kantarjian HM, Ku S, Ouspenskaia MV, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R.
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [Abstract] [Full Text] [Related]

  • 10. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):196-205. PubMed ID: 17284714
    [Abstract] [Full Text] [Related]

  • 11. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY, Xu B, Sun J, Yang Y, Niu JN.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep 07; 24(9):1051-2. PubMed ID: 15447861
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E, Bason C, Visani G, Gobbi M, Ottaviani E, Ghio R.
    Haematologica; 1994 Sep 07; 79(1):7-12. PubMed ID: 15378942
    [Abstract] [Full Text] [Related]

  • 13. Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasma.
    Guo M, Miller WM, Papoutsakis ET, Patel S, James C, Goolsby C, Winter JN.
    Cytotherapy; 1999 Sep 07; 1(3):183-94. PubMed ID: 12881174
    [Abstract] [Full Text] [Related]

  • 14. Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitro.
    Millar BC, Bell JB, Millar JL, Treleaven J, Montes A, Joffe JK, Powles RL, McElwain TJ.
    Exp Hematol; 1992 Feb 07; 20(2):209-15. PubMed ID: 1371966
    [Abstract] [Full Text] [Related]

  • 15. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML, Borbolla Escoboza JR, López-Hernández MA, González-Avante CM, FloresChapa JD, Trueba Christy E, Anaya Cuellar I.
    Rev Invest Clin; 1999 Feb 07; 51(2):77-80. PubMed ID: 10410585
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S, Hicks M, Rosenthal H, Langston A, Redei I, Torre C, Duenzl M, Feinstein B, Cherry J, Waller EK.
    Biol Blood Marrow Transplant; 2004 Dec 07; 10(12):848-57. PubMed ID: 15570253
    [Abstract] [Full Text] [Related]

  • 17. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T.
    Klin Padiatr; 2001 Dec 07; 213(4):212-38. PubMed ID: 11528556
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar 07; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 19. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
    Ottmann OG, Bug G, Krauter J.
    Semin Hematol; 2007 Jul 07; 44(3):183-92. PubMed ID: 17631182
    [Abstract] [Full Text] [Related]

  • 20. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
    Baiocchi G, Scambia G, Benedetti P, Menichella G, Testa U, Pierelli L, Martucci R, Foddai ML, Bizzi B, Mancuso S.
    Cancer Res; 1993 Mar 15; 53(6):1297-303. PubMed ID: 7680283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.